XOMA Corporation (XOMAP)

USD 25.87

(1.17%)

Market Cap (In USD)

304.81 Million

Revenue (In USD)

4.75 Million

Net Income (In USD)

-40.83 Million

Avg. Volume

1947.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
24.61-26.51
PE
-
EPS
-
Beta Value
0.9
ISIN
US98419J3059
CUSIP
98419J305
CIK
791908
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Owen P. Hughes Jr.
Employee Count
-
Website
https://www.xoma.com
Ipo Date
2020-12-16
Details
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.